Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Sphingomonas wittichii 60 kDa chaperonin (groL), partial CSB-YP404710SUF
CSB-EP404710SUF
CSB-BP404710SUF
CSB-MP404710SUF
CSB-EP404710SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii Phosphate acyltransferase (plsX) CSB-YP404711SUF
CSB-EP404711SUF
CSB-BP404711SUF
CSB-MP404711SUF
CSB-EP404711SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii Putative membrane protein insertion efficiency factor (Swit_3616) CSB-YP404712SUF
CSB-EP404712SUF
CSB-BP404712SUF
CSB-MP404712SUF
CSB-EP404712SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii Protein-export protein secB (secB) CSB-YP404713SUF
CSB-EP404713SUF
CSB-BP404713SUF
CSB-MP404713SUF
CSB-EP404713SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii 50S ribosomal protein L21 (rplU) CSB-YP404714SUF
CSB-EP404714SUF
CSB-BP404714SUF
CSB-MP404714SUF
CSB-EP404714SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii Deoxycytidine triphosphate deaminase (dcd) CSB-YP404715SUF
CSB-EP404715SUF
CSB-BP404715SUF
CSB-MP404715SUF
CSB-EP404715SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii UPF0276 protein Swit_4400 (Swit_4400) CSB-YP404716SUF
CSB-EP404716SUF
CSB-BP404716SUF
CSB-MP404716SUF
CSB-EP404716SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii UPF0246 protein Swit_4565 (Swit_4565) CSB-YP404717SUF
CSB-EP404717SUF
CSB-BP404717SUF
CSB-MP404717SUF
CSB-EP404717SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii DNA ligase (ligA), partial CSB-YP404718SUF
CSB-EP404718SUF
CSB-BP404718SUF
CSB-MP404718SUF
CSB-EP404718SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Sphingomonas wittichii Deoxyuridine 5'-triphosphate nucleotidohydrolase (dut) CSB-YP404719SUF
CSB-EP404719SUF
CSB-BP404719SUF
CSB-MP404719SUF
CSB-EP404719SUF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri 30S ribosomal protein S6 (rpsF) CSB-YP404720LLF
CSB-EP404720LLF
CSB-BP404720LLF
CSB-MP404720LLF
CSB-EP404720LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Ribosomal RNA small subunit methyltransferase G (rsmG) CSB-YP404721LLF
CSB-EP404721LLF
CSB-BP404721LLF
CSB-MP404721LLF
CSB-EP404721LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Phosphoribosylformylglycinamidine synthase 2 (purL), partial CSB-YP404722LLF
CSB-EP404722LLF
CSB-BP404722LLF
CSB-MP404722LLF
CSB-EP404722LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP404723LLF
CSB-EP404723LLF
CSB-BP404723LLF
CSB-MP404723LLF
CSB-EP404723LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Alanine racemase (alr) CSB-YP404724LLF
CSB-EP404724LLF
CSB-BP404724LLF
CSB-MP404724LLF
CSB-EP404724LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri 50S ribosomal protein L11 (rplK) CSB-YP404725LLF
CSB-EP404725LLF
CSB-BP404725LLF
CSB-MP404725LLF
CSB-EP404725LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Probable tRNA threonylcarbamoyladenosine biosynthesis protein Gcp (gcp) CSB-YP404726LLF
CSB-EP404726LLF
CSB-BP404726LLF
CSB-MP404726LLF
CSB-EP404726LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri SsrA-binding protein (smpB) CSB-YP404727LLF
CSB-EP404727LLF
CSB-BP404727LLF
CSB-MP404727LLF
CSB-EP404727LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Holliday junction ATP-dependent DNA helicase RuvA (ruvA) CSB-YP404728LLF
CSB-EP404728LLF
CSB-BP404728LLF
CSB-MP404728LLF
CSB-EP404728LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Lactobacillus reuteri Probable inorganic polyphosphate/ATP-NAD kinase (ppnK) CSB-YP404729LLF
CSB-EP404729LLF
CSB-BP404729LLF
CSB-MP404729LLF
CSB-EP404729LLF-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開(kāi)發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開(kāi)發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>